Crystallics is part of the Drug Development Cluster

Drug development is a challenging business. Success rates tell a chilling story....so why make it more difficult? Traditional models of outsourced drug development encompass two models: the one-stop shop, and the group of independent Contract Research Organizations (CROs). Neither is ideal. However, there is now an optimal third-way....

Drug Development Cluster

The Drug Development Cluster offers a novel integrated set of drug development services to support small molecule pre-clinical Research and Development (R&D), all delivered in a seamless fashion from a group of industry-leading CROs. From discovery services to IND/IMPD, the members of the cluster have built an excellent track record within pharmaceutical development over the last 10-15 years.

The Drug Development Cluster is an outsourcing model that incorporates the best of two worlds: a set of expert services provided by a team of independent companies whilst maintaining speed, flexibility and optimal project management. End-to-end project visibility through the cluster and across the companies ensures that your project is always kept on track, optimizing the use of time and money….and minimizing risk. Plan for success….quicker to milestone translates to quicker to market!

Transparent project planning, commitment to delivery, and full flexibility are key values for the Drug Development Cluster. There is no need to commit to a full set of services. Choose your collaborator to match the project requirements, but in the knowledge that other team members are available to assist if required. We can organize a single CDA, one ChemPharm project plan, one reporting format and even a single dedicated project manager to minimize the number of external interfaces.

We are your virtual development team. We work together, closely managing activities with a shared objective. Rest assured in the knowledge that we understand that your project is not a compilation of independent deliverables: we all focus on the milestone, whether pre-clinical or submission. The Drug Development Cluster provides support to Biotech companies and for mature Pharma wishing to outsource projects involving a broad set of services.

The benefits of working with the Drug Development Cluster:

- A single entry point to a set of independent expert service providers

- Centralized project management and aligned operations

- One CDA, one quote, one contact, one report

- Reduction of R&D cost by reduction of overlapping activities

- Shorten development timelines by working in parallel

- Centralized access to a network of specialty technologies and services

The partners in the Drug Development Cluster are: Crystallics (previously Avantium Pharma), Cambridge Major Labs, Mercachem, Notox and Seps Pharma.

For further information please visit: www.drugdevelopmentcluster.com